202 related articles for article (PubMed ID: 36599883)
21. Downregulated miR‑29a promotes B cell overactivation by upregulating Crk‑like protein in systemic lupus erythematosus.
Shi X; Ye L; Xu S; Guo G; Zuo Z; Ye M; Zhu L; Li B; Xue X; Lin Q; Ding X
Mol Med Rep; 2020 Aug; 22(2):841-849. PubMed ID: 32467986
[TBL] [Abstract][Full Text] [Related]
22. The exploration of shared genes and molecular mechanisms of systemic lupus erythematosus and atherosclerosis.
Fan JL; Wu D; Zhu TT; Tian XL; Liu SJ; Zhang SL
Lupus; 2023 Feb; 32(2):239-251. PubMed ID: 36480924
[TBL] [Abstract][Full Text] [Related]
23. Uncovering lupus nephritis-specific genes and the potential of TNFRSF17-targeted immunotherapy: a high-throughput sequencing study.
Zou X; Yang M; Ye Z; Li T; Jiang Z; Xia Y; Tan S; Long Y; Wang X
Front Immunol; 2024; 15():1303611. PubMed ID: 38440734
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of Signaling Pathways Due to Differentially Expressed Genes From the B-Cell Transcriptomes of Systemic Lupus Erythematosus Patients - A Bioinformatics Approach.
Udhaya Kumar S; Thirumal Kumar D; Siva R; George Priya Doss C; Younes S; Younes N; Sidenna M; Zayed H
Front Bioeng Biotechnol; 2020; 8():276. PubMed ID: 32426333
[TBL] [Abstract][Full Text] [Related]
26. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of tRNA-derived small RNAs and their potential roles in lupus nephritis.
Liang Y; Zhang J; Qiu W; Chen B; Zhou Y; Chen X; Shentu Y; Zhang H; Bai Y; Chen C
Lupus; 2021 Dec; 30(14):2248-2255. PubMed ID: 34923866
[TBL] [Abstract][Full Text] [Related]
28. Identification of IFI44L as a new candidate molecular marker for systemic lupus erythematosus.
Wang Y; Jia W; Ma Q; Li F; Ma Z; Yang M; Pu J; Huo Z; Dang J
Clin Exp Rheumatol; 2023 Jan; 41(1):48-59. PubMed ID: 35349411
[TBL] [Abstract][Full Text] [Related]
29. Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive RNA-sequencing transcriptome profiling.
Ahir BK; Lakka SS
Cell Signal; 2019 Jan; 53():22-38. PubMed ID: 30244172
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of ATAC-seq and RNA-seq reveals the transcriptional regulation network in SLE.
Wu J; Li Y; Feng D; Yu Y; Long H; Hu Z; Lu Q; Zhao M
Int Immunopharmacol; 2023 Mar; 116():109803. PubMed ID: 36738683
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of hub gene CXCL10 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Zhang R; Li Y; Pan B; Li Y; Liu A; Li X
Exp Ther Med; 2019 Nov; 18(5):4067-4075. PubMed ID: 31616519
[TBL] [Abstract][Full Text] [Related]
32. Exploring the potential common denominator pathogenesis of system lupus erythematosus with COVID-19 based on comprehensive bioinformatics analysis.
Zeng H; Zhuang Y; Li X; Yin Z; Huang X; Peng H
Front Immunol; 2023; 14():1179664. PubMed ID: 37426642
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive bioinformatics analysis reveals the crosstalk genes and immune relationship between the systemic lupus erythematosus and venous thromboembolism.
Yu J; Yang J; He Q; Zhang Z; Xu G
Front Immunol; 2023; 14():1196064. PubMed ID: 37465678
[TBL] [Abstract][Full Text] [Related]
34. Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus.
Rai G; Rai R; Saeidian AH; Rai M
Immunol Res; 2016 Feb; 64(1):14-24. PubMed ID: 26188428
[TBL] [Abstract][Full Text] [Related]
35. Overall Downregulation of mRNAs and Enrichment of H3K4me3 Change Near Genome-Wide Association Study Signals in Systemic Lupus Erythematosus: Cell-Specific Effects.
Zhang Z; Shi L; Song L; Maurer K; Petri MA; Sullivan KE
Front Immunol; 2018; 9():497. PubMed ID: 29593737
[TBL] [Abstract][Full Text] [Related]
36. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
[TBL] [Abstract][Full Text] [Related]
37. Investigating the causal relationship and potential shared diagnostic genes between primary biliary cholangitis and systemic lupus erythematosus using bidirectional Mendelian randomization and transcriptomic analyses.
Tao T; Tang A; Lv L; Yuan J; Wu L; Zhao L; Chen J
Front Immunol; 2024; 15():1270401. PubMed ID: 38464525
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.
Tang D; Chen Y; He H; Huang J; Chen W; Peng W; Lu Q; Dai Y
BMC Genomics; 2016 Jul; 17():488. PubMed ID: 27402083
[TBL] [Abstract][Full Text] [Related]
39. miR‑101‑3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF‑κB pathway.
Zhao X; Li S; Wang Z; Bai N; Feng Y
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760166
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
